Jeisys Medical

- Jeisys Medical strengthened its global brand presence by participating in consecutive international conferences held in the United States and Thailand. - Participation in ASLMS in the U.S.… Official launch of the American subsidiary signals a push into the North American market - Caught the attention of global medical professionals at ICLAS in Thailand… Expanding brand recognition in the Asian market - Expanded local networks in Southeast Asia through experiential marketing, such as webinars and photo zones for medical professionals     Jeisys Medical, a global medical aesthetics company, is accelerating its entry into international markets and has been met with an enthusiastic response in both the United States and Asia. Jeisys Medical recently strengthened its global brand by attending international conferences in the U.S. and Thailand in succession. In particular, the company drew attention by officially announcing the establishment of a local corporation aimed at entering the U.S. market.   From April 24 to 26, Jeisys Medical participated in the 2025 American Society for Laser Medicine & Surgery (ASLMS) held in Orlando, Florida. At this event, Jeisys Medical made official the establishment of JEISYS MEDICAL NORTH AMERICA INC., which is tailored to the U.S. aesthetic medical device market, announcing plans to further strengthen its global brand identity and expand its presence in the market.   During the conference, Jeisys Medical showcased three flagship products—DENSITY, LinearZ, and SmoothCool—and highlighted the technological advantages and clinical cases of DENSITY, which utilizes radiofrequency energy, during the Thursday Lunch & Learn session. This strengthened the company's network with local medical professionals and is expected to facilitate a swift entry into the U.S. market.   At the same time, Jeisys Medical participated in the 2025 ICLAS in BANGKOK, held in Bangkok, Thailand, drawing the attention of medical professionals from around the world. Aiming to expand brand awareness in the Asia-Pacific market, the company focused on introducing the technology and clinical efficacy of DENSITY and LinearZ. At the venue, Jeisys Medical expanded its global network through step-by-step webinars and experiential marketing designed to reflect the cultural characteristics of local medical professionals.   A Jeisys Medical representative stated, “The establishment of the U.S. subsidiary is an important turning point for expanding into the global market. In addition to the United States and Thailand, we plan to continue participating in major international conferences such as IMCAS ASIA, and we will actively utilize both online and offline channels to raise brand awareness and further strengthen our presence in overseas markets with innovative products.”

                       -POTENZA ranked No.1 in the laser lifting medical device category by a wide margin in a survey with over 620000 participants Highly preferred for its 14 customized tips allowing precise treatment tailored to various skin conditions A Jeisys Medical representative remarked, “A great opportunity to once again prove the brand’s reliability and market presence.”   Global medical aesthetic company Jeisys Medical Co., Ltd.’s high-frequency device POTENZA has won first place in the laser lifting medical device category at the “2025 Brand Customer Loyalty Grand Prize” hosted by the Korea Consumer Forum. This annual award is co-hosted by Brand Keys, one of the top 10 U.S. research and consulting agencies, and the Korea Consumer Forum, selecting the top customer loyalty brands in each category. The 2025 evaluation was conducted between March 17 and March 30 , with 622574 participants responding through an online survey (50%) and one-on-one telephone interviews (50%) POTENZA ranked No.1 with an overwhelming lead in the industry, reaffirming its brand trust and market dominance. POTENZA, which recently surpassed 4000 cumulative global sales, is an RF (Radio Frequency) device that offers personalized treatment for different skin concerns through 14 tips—11 invasive and 3 non-invasive. It delivers thermal energy to the dermis or epidermis to induce coagulation. Notably, its pumping tips (CP-16, CP-25) assist practitioners in diverse procedural protocols through positive pressure generated as needles are withdrawn. A Jeisys Medical representative stated, “This award for POTENZA is thanks to the unwavering trust and support of our consumers. We will continue to enhance satisfaction through ongoing innovation and customer-focused service.”

Jeisys Medical promotes products and expands network at KOAT Spring Conference on April 13 Showcased three flagship devices—Density, LinearZ, Potenza—to present cutting-edge technology Featured in “Safe and Effective Facial Tightening Strategies” session to strengthen connections with physicians and boost brand awareness ▲ Jeisys Medical Co., Ltd. exhibited its flagship products—Density, LinearZ, and Potenza—at the 2025 KOAT Spring Conference held on April 13 at the Grand InterContinental Seoul Parnas. Jeisys Medical Co., Ltd., a global medical aesthetics company, announced its successful participation in the 2025 Korean Obesity & Aesthetic Treatment (KOAT) Spring Conference held on April 13 at the Grand InterContinental Seoul Parnas in Samseong-dong, Seoul. The KOAT Spring Conference is Korea’s largest academic event in the fields of obesity and aesthetic medicine, bringing together experts to share the latest research and treatment methods. Each year, it serves as a vital platform for academic exchange and technological advancement, attracting dermatologists, plastic surgeons, and professionals from the industry. At this year’s conference, Jeisys Medical actively promoted its leading aesthetic devices—Density, LinearZ, and Potenza—to medical professionals and stakeholders. The company drew strong attention by directly demonstrating its technologies and clinical effectiveness through its booth and presentations. A Jeisys Medical representative stated, “Our participation in this year’s KOAT Spring Conference provided a valuable opportunity to strengthen connections with local medical professionals and exchange the latest trends in aesthetic medicine,” adding, “We will continue to actively participate in various academic events and exhibitions to expand our presence in both domestic and global markets.” Founded in 2004, Jeisys Medical is a global leader in aesthetic medical devices, offering a wide range of solutions based on HIFU, RF, and laser technologies. Its flagship products include Density (RF), Potenza (RF), and LinearZ (HIFU). The company is committed to delivering effective aesthetic solutions in collaboration with medical professionals worldwide.

Jeisys Medical successfully concluded its participation in ‘IMCAS Americas 2025’ held from April 11 (Fri) to 13 (Sun) Introduced ‘DENSITY’ and ‘LinearZ’ to strengthen brand awareness in the Latin American market and attract attention Expected to increase product demand through active networking with key KOLs and speakers in the region   ▲Jeisys Medical Co., Ltd. participated in ‘IMCAS Americas 2025’, held from April 11 to 13 at the World Trade Center São Paulo in Brazil, drawing high attention from buyers and experts in the region by introducing its flagship devices, Density and LinearZ. Global medical aesthetics company Jeisys Medical Co., Ltd. accelerated its entry into the Latin American market by participating in the global aesthetic conference ‘IMCAS Americas 2025’, held from April 11 to 13 at the World Trade Center São Paulo, Brazil. IMCAS Americas is the largest aesthetic and clinical conference in Latin America, where plastic surgeons, dermatologists, and aesthetic professionals gather to share the latest technologies and research. Jeisys presented its radiofrequency-based medical aesthetic device ‘DENSITY’ and ultrasound-based device ‘LinearZ’ to officially introduce the products to the region. By highlighting its differentiated technology, Jeisys actively engaged with key opinion leaders (KOLs) and potential customers, establishing meaningful connections to expand its sales and distribution channels in the Latin American market. In particular, booth visitors showed strong interest in Jeisys’s representative product, Density. Density delivers 6.78 MHz radiofrequency energy to the skin and applies both monopolar and bipolar RF modes in sequence. A Jeisys Medical representative stated, “Our participation in IMCAS Americas 2025 provided a valuable opportunity to build stronger networks with top experts and enhance our brand awareness in the Latin American market,” adding, “We plan to launch active promotional campaigns in Brazil and other Latin American countries to expand product sales and distribution, and will continue to reinforce our presence in the global market through customized strategies for each region.” Meanwhile, Jeisys Medical has been accelerating its global expansion since the beginning of the year. Starting with ‘IMCAS World Congress 2025’ held in Paris from January 30 to February 1, the company has been actively participating in major global congresses, and its involvement in ‘IMCAS Americas 2025’ reflects this ongoing strategy.